Video

Impact on Pharmacies From the Move Toward Value-Based Care

Tony Willoughby, McKesson vice president and chief pharmacist at Health Mart, talks about the impact from the move toward value-based care will have on pharmacies.

Tony Willoughby, McKesson vice president and chief pharmacist at Health Mart, talks about the impact from the move toward value-based care will have on pharmacies.

This interview was recorded at the Pharmacy Development Services 2015 conference in Orlando, Florida.

Related Videos
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit: Peter Hansen | stock.adobe.com
Older patient with medical health checkup with cardiologist or geriatric doctor. Woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Related Content
Close-up of the wooden gavel and stethoscope on desk with male doctor using a laptop. Concept of medical law and medical crimes - Image credit: inthasone | stock.adobe.com
May 23rd 2025

Individual Is Charged With a Variety of Serious Federal Charges Related to Medications

Joseph L. Fink III, JD, BSPharm, DSc (Hon), FAPhA
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Visualization of human body with COPD highlighted on lungs | Image Credit: © Lila Patel - stock.adobe.com
May 22nd 2025

FDA Approves Mepolizumab for Treatment of Patients With COPD and an Eosinophilic Phenotype

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder
March 31st 2025

Pharmacy Focus: Integrating SBIRT in Pharmacies to Combat Substance Use Disorder

Luke Halpern, Assistant Editor
Adalimumab Medical Injection - Image credit: luchschenF | stock.adobe.com
May 22nd 2025

FDA Grants Interchangeability Designation to Yuflyma, Biosimilar for Humira Across All Approved Doses

Kennedy Ferruggia, Assistant Editor
Medical Illustration Atherosclerosis, Cholesterol Plaque, Blood Clot in Artery, Cardiovascular Disease.
May 22nd 2025

Risk of Cardiovascular Event Increases With Rising Lipoprotein(a) Levels in Patients With ASCVD

Luke Halpern, Assistant Editor